Marten Hansen

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

ATMPs prepared under hospital exemption: European Blood Alliance position paper.

ATMPs prepared under hospital exemption: European Blood Alliance position paper.

Journal: HemaSphere

Published: August 05, 2025

Heterozygous nonsense FLI1 p.Met100∗ variant results in thrombocytopenia and increased erythroid gene expression.

Heterozygous nonsense FLI1 p.Met100∗ variant results in thrombocytopenia and increased erythroid gene expression.

Journal: Research and practice in thrombosis and haemostasis

Published: July 09, 2025

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Journal: The British journal of surgery

Published: December 24, 2024

LSD1/KDM1A and GFI1B repress endothelial fate and induce hematopoietic fate in induced pluripotent stem cell-derived hemogenic endothelium.

LSD1/KDM1A and GFI1B repress endothelial fate and induce hematopoietic fate in induced pluripotent stem cell-derived hemogenic endothelium.

Journal: Haematologica

Published: February 01, 2024

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Journal: The New England journal of medicine

Published: December 08, 2022

Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes.

Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes.

Journal: EJNMMI research

Published: June 20, 2021

The RNA-Binding Protein ATXN2 is Expressed during Megakaryopoiesis and May Control Timing of Gene Expression.

The RNA-Binding Protein ATXN2 is Expressed during Megakaryopoiesis and May Control Timing of Gene Expression.

Journal: International journal of molecular sciences

Published: December 13, 2019

Human-induced pluripotent stem cell-derived blood products: state of the art and future directions.

Human-induced pluripotent stem cell-derived blood products: state of the art and future directions.

Journal: FEBS letters

Published: July 19, 2019

CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1.

CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1.

Journal: Blood cancer journal

Published: October 28, 2018

Molecular mechanisms of bleeding disorderassociated GFI1BQ287* mutation and its affected pathways in megakaryocytes and platelets.

Molecular mechanisms of bleeding disorderassociated GFI1BQ287* mutation and its affected pathways in megakaryocytes and platelets.

Journal: Haematologica

Published: March 30, 2018

Efficient production of erythroid, megakaryocytic and myeloid cells, using single cell-derived iPSC colony differentiation.

Efficient production of erythroid, megakaryocytic and myeloid cells, using single cell-derived iPSC colony differentiation.

Journal: Stem cell research

Published: January 19, 2018

Generation of human erythroblast-derived iPSC line using episomal reprogramming system.

Generation of human erythroblast-derived iPSC line using episomal reprogramming system.

Journal: Stem cell research

Published: June 13, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026